Andrew J. Gentles

44.9k citations

104 papers · 19.5k indexed · 6 hit papers · h-index 45

Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 16
Immunology top 0.2%
Oncology top 0.2%
- CAR-T cell therapy research 9
Pulmonary and Respiratory Medicine top 0.2%
Molecular Biology top 0.5%
- Single-cell and spatial transcriptomics 13
- Gene expression and cancer classification 9
- Bioinformatics and Genomic Networks 9
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 16
Hematology
- Acute Myeloid Leukemia Research 12
Plant Science
- Chromosomal and Genetic Variations 12

Co-authors: Ash A. Alizadeh Maximilian Diehn Chih Long Liu Aaron M. Newman Weiguo Feng Chuong D. Hoang Yue Xu Michael R. Green
Cited by: Cancer Research Immunology Oncology
Journals: Nature (1 paper)Cell (1 paper)Proceedings of the National Academy of Sciences (8 papers)
Partner nations: United States India Canada

In The Last Decade

Andrew J. Gentles

102 papers receiving 19.3k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Machine Intelligence
2019 Nature Biotechnology
2015 Nature Medicine
2015 Nature Methods
2010 Science Translational Medicine
2006 BMC Bioinformatics

Peers

Countries citing papers authored by Andrew J. Gentles

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Gentles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Gentles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Gentles more than expected).

Fields of papers citing papers by Andrew J. Gentles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Gentles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Gentles. The network helps show where Andrew J. Gentles may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew J. Gentles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew J. Gentles Line = papers co-authored together Andrew J. Gentles links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients Clinical Cancer Research ·Corrine A. Nief,Phoebe M. Hammer,Aihui Wang,Vivek Charu,Amina Tanweer,Babak Litkouhi,Elizabeth Kidd,Andrew J. Gentles,Brooke E. Howitt	2024	1
2	Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity Leukemia ·Matthew Schwede,Katharina Jahn,Jack Kuipers,Linde A. Miles,Robert L. Bowman,Troy M. Robinson,Ken Furudate,Hidetaka Uryu,Tomoyuki Tanaka,Yuya Sasaki,Asiri Ediriwickrema,Brooks A. Benard,Andrew J. Gentles,Ross L. Levine,Niko Beerenwinkel,Koichi Takahashi,Ravindra Majeti	2024	10
3	Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer Genome Medicine ·Kevin Brennan,Almudena Espín-Pérez,Serena Chang,Nikita Bedi,Saumyaa Saumyaa,June Ho Shin,Sylvia K. Plevritis,Olivier Gevaert,John B. Sunwoo,Andrew J. Gentles	2023	3
4	Translatome analysis reveals microglia and astrocytes to be distinct regulators of inflammation in the hyperacute and acute phases after stroke Glia ·Victoria G. Hernandez,Kendra J. Lechtenberg,Todd C. Peterson,Li Zhu,Tawaun A. Lucas,Karen P. Bradshaw,Justice O. Owah,Alanna Dorsey,Andrew J. Gentles,Marion S. Buckwalter	2023	25
5	Profiling Cellular Ecosystems at Single-Cell Resolution and at Scale with EcoTyper Methods in molecular biology ·Chloé B. Steen,Bogdan Luca,Ash A. Alizadeh,Andrew J. Gentles,Aaron M. Newman	2023	1
6	The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma Cancer Cell ·Chloé B. Steen,Bogdan Luca,Mohammad Shahrokh Esfahani,Armon Azizi,Brian J. Sworder,Barzin Y. Nabet,David M. Kurtz,Chih Long Liu,Farnaz Khameneh,Ranjana H. Advani,Yasodha Natkunam,June H. Myklebust,Maximilian Diehn,Andrew J. Gentles,Aaron M. Newman,Ash A. Alizadeh	2021	149
7	Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia Nature Communications ·Brooks A. Benard,Logan B. Leak,Armon Azizi,Danièl Thomas,Andrew J. Gentles,Ravindra Majeti	2021	36
8	High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment Cell Reports ·Veronica D. Gonzalez,Ying-Wen Huang,Antonio Delgado‐González,Shih‐Yu Chen,Kenyi Donoso,Karen Sachs,Andrew J. Gentles,Grace M. Allard,Kevin S. Kolahi,Brooke E. Howitt,Ermelinda Porpiglia,Wendy J. Fantl	2021	52
9	MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity eLife ·Renumathy Dhanasekaran,Virginie Baylot,Minsoon Kim,Sibu Kuruvilla,David I. Bellovin,Nia Adeniji,Anand Rajan,Ian Lai,Meital Gabay,Ling Tong,Maya S. Krishnan,Jangho Park,Theodore Hu,Mustafa A. Barbhuiya,Andrew J. Gentles,Kasthuri Kannan,Phuoc T. Tran,Dean W. Felsher	2020	46
10	Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making American Journal of Neuroradiology ·Michael Iv,Xiaobai Liu,Jonathan Lavezo,Andrew J. Gentles,Reem Ghanem,Seth Lummus,Donald E. Born,Scott G. Soltys,Seema Nagpal,Reena Thomas,Lawrence D. Recht,Nancy J. Fischbein	2019	29
11	GFPT2 -Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma Cancer Research ·Weiruo Zhang,Gina Bouchard,Alice Yu,Mājid Shafiq,Mehran Jamali,Joseph B. Shrager,Kelsey Ayers,Shaimaa Bakr,Andrew J. Gentles,Maximilian Diehn,Andrew Quon,Robert B. West,Viswam S. Nair,Matt van de Rijn,Sandy Napel,Sylvia K. Plevritis	2018	87
12	Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance Cancer Discovery ·Youngtae Jeong,Ngoc T. Hoang,Alexander F. Lovejoy,Henning Stehr,Aaron M. Newman,Andrew J. Gentles,William Kong,Diana Truong,Shanique Martin,Aadel A. Chaudhuri,Diane Heiser,Li Zhou,Carmen Say,Justin N. Carter,Susan M. Hiniker,Billy W. Loo,Robert B. West,Philip A. Beachy,Ash A. Alizadeh,Maximilian Diehn	2016	243
13	Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages Proceedings of the National Academy of Sciences ·James Scott McClellan,Christopher G. Dove,Andrew J. Gentles,Christine E. Ryan,Ravindra Majeti	2015	44
14	CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia Cell stem cell ·Masayuki Iwasaki,Michaela Liedtke,Andrew J. Gentles,Michael L. Cleary	2015	89
15	Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia JAMA ·Andrew J. Gentles	2010	264
16	Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas Blood ·Kristopher A. Sarosiek,Raquel Malumbres,Hovav Nechushtan,Andrew J. Gentles,Eli Avisar,Izidore S. Lossos	2009	66
17	A Bayesian nonparametric method for model evaluation: application to genetic studies Journal of nonparametric statistics ·Babak Shahbaba,Andrew J. Gentles,Joseph Beyene,Sylvia K. Plevritis,Celia M.T. Greenwood	2009	1
18	Genomic and Proteomic Analysis Reveals a Threshold Level of MYC Required for Tumor Maintenance Cancer Research ·Catherine M. Shachaf,Andrew J. Gentles,Sailaja Elchuri,Debashis Sahoo,Yoav Soen,Orr Sharpe,Omar D. Perez,Maria Chang,Dennis Mitchel,William H. Robinson,David L. Dill,Garry P. Nolan,Sylvia K. Plevritis,Dean W. Felsher	2008	70
19	Annotation of the Drosophila genome Nature ·Samuel Karlin,Aviv Bergman,Andrew J. Gentles	2001	25
20	Genome-Scale Compositional Comparisons in Eukaryotes Genome Research ·Andrew J. Gentles,Samuel Karlin	2001	140

About Andrew J. Gentles

Andrew J. Gentles is a scholar working on Cancer Research, Hematology and Immunology, having authored 104 papers that have together received 19.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Single-cell and spatial transcriptomics (13 papers), Acute Myeloid Leukemia Research (12 papers), Chromosomal and Genetic Variations (12 papers), Gene expression and cancer classification (9 papers), CAR-T cell therapy research (9 papers) and Bioinformatics and Genomic Networks (9 papers). The work is most often cited by research in Cancer Research (4.7k citations), Immunology (5.9k citations) and Oncology (6.3k citations). Andrew J. Gentles has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Ash A. Alizadeh, Maximilian Diehn, Chih Long Liu, Aaron M. Newman, Weiguo Feng, Chuong D. Hoang, Yue Xu, Michael R. Green, Sylvia K. Plevritis and Jerzy Jurka. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact